1Mather KJ,Verma S,Anderson TJ.Improved endothelial function with metformin in type 2 diabetes mellitus[J].J Am Coll Cardiol,2001,37(5):1344-1350.
2Mogul HR,Peterson SJ,Weinstein BI,et al.Metformin and carbohydrate-modified diet, a novel obesity treatment protocol:preliminary findings from a case series of non-diabetic women with midlife weight gain and hyperinsulinemia[J].Heart Disease,2001,3(5):285-292.
3American Diabetes Association and National Institute of Diabetes,Digestive and Kidney Diseases.The prevention or delay of type 2 diabetes[J].Diabetes Care,2002,25(4):742-749.
4Brady PA.Sulfonylurea drugs in patients with diabetes mellitus and cardiovascular disease[J].Cardiovasc Rev Rep,2002,23(1):85-88.
5Hanefeld M,Bouter KP, Dickinson S, et al. Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia[J].Diabetes Care,2000,23(2):202-207.
6Plosker GL,Figgitt DP.Repaglinide:a pharmacoeconomic review of its use in type 2 diabetes mellitus[J].Pharmacoeconomics,2004,22(6):389-411.
8Landgraf R,Frank M,Bauer C,et al.Prandial glucose regulation with repaglinide:its clinical and lifestyle impact in a large cohort of patients with type 2 diabetes[J].Int J Obes Relat Metab Disord,2000,24(Suppl 3):38-44.
9Maggs DG,Buchanan TA,Burant CF,et al.Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus.A randomized, double-blind,placebo-controlled trial[J].Ann Intern Med,1998,128(3):176-185.
10Pavo I,Jermendy G,Varkonyi TT,et al.Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes[J].J Clin Endocrinol Metab,2003,88(4):1637-1645.
